1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Morphea: new trials by email Literature Review of Morphea trials Research Report on Morphea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea) FCX-013, veledimex - Morphea, Scleroderma, Localized | Phase 1 / Phase 2 | Terminated | Castle Creek Biosciences, LLC. | 1 | 2019-12-18 | 2024-01-23 |
| Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea Crisaborole - Morphea | Phase 2 | Completed | Duke University | 8 | 2018-09-01 | 2021-04-01 |
Scleroderma, Localized (2) · Scleroderma, Diffuse (1)
Connective Tissue Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Scleroderma, Systemic (1)
Drug Delivery Systems (1) · crisaborole (1) · veledimex (1)
Castle Creek Biosciences, LLC. (1) · Duke University (1)
United States (2)